India, July 31 -- Biotechnology company Biogen, Inc. (BIIB) reported Thursday that net income attributable to the company for the second quarter grew to $634.8 million or $4.33 per share from $583.6 million or $4.00 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter were $5.47 per share, compared to $5.28 per share in the year-ago quarter.
On average, 26 analysts polled expected the company to report earnings of $3.87 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenue for the quarter grew 7 percent to $2.65 billion from $2.46 billion in the same quarter last year. Revenues were up 8 percent in constant currency. Analysts expected revenues of $2.32 billion for...